Start-Ups To Once Again Play Starring Role at MEDICA 2024
By LabMedica International staff writers Posted on 07 Nov 2024 |

The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62 countries from Armenia to China and America to Rwanda. They will be exhibiting their innovative solutions on the MEDICA INNOVATION FORUM stage as part of MEDICA (Düsseldorf, Germany), the leading international trade fair for the healthcare and medical equipment industries to be held in Düsseldorf from 11 to 14 November 2024.
At the MEDICA INNOVATION FORUM alone, more than 120 luminaries – including global players such as Microsoft, HP, HTC, 3M, Roche, Huawei, and KUKA – will be showcasing and discussing groundbreaking innovations and best practices. Key topics will include generative AI and big data, robotics, XR and digital twins, mobile health and medical wearables, 3D printing, the Internet of Medical Things and solutions for the hospitals of the future. The MEDICA INNOVATION FORUM will also provide a meeting place and networking platform, “Women Leaders in Healthcare.” With this year’s record participation of 60 young businesses, the MEDICA START-UP PARK will be offering visiting professionals the opportunity to familiarize themselves with a host of other exciting health start-ups and their innovations.
This year’s top 12 health techpreneurs will be presenting their solutions in the pitch final at the 16th Healthcare Innovation World Cup. This will take place on stage at the MEDICA INNOVATION FORUM, where speakers will showcase the next generation of smart health devices, medical wearables, XR solutions, digital biomarkers, electroceuticals, and smart bandages. Finalists Saventic Health, U-Care Medical Srl, and IQONIC.AI are all in on artificial intelligence. Saventic uses AI to detect rare diseases, U-Care to improve clinical outcomes in intensive care units, and IQONIC.AI provides AI-supported dermatology solutions for analyzing skin conditions and issuing personalized treatment recommendations based on advanced imaging technology.
The robotics category will be represented in the final by Robota, Robeauté, and Goodbot. Specifically, Robeauté is supporting the medical profession by supplying neurosurgical micro-robots. Robota offers an automated system for sterilizing surgical instruments, while Goodbot provides an innovative pipetting robot. Doctorderma, Vertify GmbH, and PharmaTrail AG will present their health apps. PharmaTrail develops digital solutions to streamline and optimize clinical trial management to improve efficiency and data accuracy in pharmaceutical research. AGED Diagnostics, Fepod Oy Ltd., and Dxcover are focused on laboratory diagnostics. For example, Dxcover will present an innovative liquid biopsy technology for the early detection of cancer via a simple blood test.
At an exciting onstage program, 3D printing will be the subject of discussion, before attention turns to innovative prosthetics, orthotics, and similar applications. The future of therapy will also be the center of attention at the forum. The series of talks will run the gamut from digital tools for home patient care to robot-assisted surgery, rehabilitation, and assistive technologies. The final day at the MEDICA INNOVATION FORUM will include an international flavor, with healthcare hubs from Finland, France, Germany, Taiwan, and Japan presenting their organizations. This will also offer a perfect segue into the MEDICA START-UP PARK near the forum stage. In this space, start-ups from all over the world – including Germany, Italy, India, Japan, Taiwan, Switzerland, and the United States – will be putting their innovations for healthcare on show.
Related Links:
MEDICA
Latest Industry News
- Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
- Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
- Research Collaboration to Advance AI-Enhanced, Real-Time Optical Imaging in Lung Cancer Biopsy
- CACLP 2025 Unites Global Innovators in IVD Industry
- Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
- ABL Signs Know-How License and Transfer Agreement for Siemens’ Fast Track Diagnostics PCR Portfolio
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- New Partnership Revolutionizes Analyses of Biological Samples
- Medlab Middle East Looks to The Future of Laboratories
- Medix Biochemica Acquires German Immunoassay Solutions Developer Candor Bioscience
- bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics
- Danaher Partners with Healthcare AI Company Innovaccer on Novel Digital and Diagnostic Solutions
- OraSure Technologies Acquires Sherlock Biosciences
- Worldwide Initiative Aims to Develop Globally Generalizable Blood-Based Tests for Alzheimer’s Disease
- Hologic Enters into Agreement with CDC for H5N1 Bird Flu Test Development
- Quanterix Acquires Magnetic Bead Tech Firm Emission
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
Simple DNA PCR-Based Lab Test to Enable Personalized Treatment of Bacterial Vaginosis
Approximately one in three women aged 14-49 in the United States will experience bacterial vaginosis (BV), a vaginal bacterial imbalance, at some point in their lives. Around 50% of BV cases do not present... Read more
Rapid Diagnostic Test to Halt Mother-To-Child Hepatitis B Transmission
Hepatitis B, an inflammation of the liver caused by the hepatitis B virus (HBV), is the second-leading infectious cause of death globally, following tuberculosis. This viral infection can result in serious... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read moreCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read moreInnovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read morePathology
view channel
New AI Model Predicts Gene Variants’ Effects on Specific Diseases
In recent years, artificial intelligence (AI) has greatly enhanced our ability to identify a vast number of genetic variants in increasingly larger populations. However, up to half of these variants are... Read more
Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read moreTechnology
view channel
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
Royal Philips (Amsterdam, The Netherlands) has expanded its partnership with Ibex Medical Analytics (Tel Aviv, Israel) and released the new Philips IntelliSite Pathology Solution (PIPS) to further accelerate... Read more
Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
Grifols (Barcelona, Spain), a manufacturer of plasma-derived medicines and innovative diagnostic solutions, has entered into a strategic agreement with Inpeco (Novazzano, Switzerland), a global leader... Read more